US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COYA THERAPEUTICS INC

4.55

+0.13002.94%

Post-market: 4.550.00000.00%16:14 EDT

Volume:100.31K

Turnover:450.06K

Market Cap:106.68M

PE:-4.18

High:4.58

Open:4.50

Low:4.36

Close:4.42

52wk High:7.75

52wk Low:3.71

Shares:23.45M

Float Shares:17.54M

Volume Ratio:1.14

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0897

EPS(LYR):-1.2700

ROE:-60.54%

ROA:-32.27%

PB:2.47

PE(LYR):-3.58

Loading ...

Overview Company News Filings

Coya Therapeutics Initiated at Buy by Roth Capital

Coya Therapeutics initiated with a Buy at Roth Capital

Coya Therapeutics releases investor presentation on Treg-directed combination therapies for neurodegenerative diseases

Coya Therapeutics presents ALSTARS Phase 2 trial design at ALS Drug Development Summit

Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)

Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street

Coya Therapeutics announces annual shareholder meeting

Coya Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Coya Therapeutics: Entered Into Sales Agreement, May Offer and Sell From Time to Time Shares of Co's Common Stock for up to $30 Mln

THOMSON REUTERS

Coya Therapeutics enters at-the-market equity sales agreement for up to $30 million stock offering

Coya Therapeutics granted FDA Fast Track Designation for COYA 302

Coya Therapeutics Q1 FY26 net loss narrows to $7.2 million

Coya Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

THOMSON REUTERS

Coya Therapeutics Q1 Net Income USD -7.2 Million

THOMSON REUTERS

Coya Therapeutics wins FDA fast track status for ALS drug COYA 302

Coya Therapeutics Inc - Conducting Phase 2 Alstars Trial of Coya 302 for ALS

THOMSON REUTERS

Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for Coya 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

THOMSON REUTERS

Coya Therapeutics Inc expected to post a loss of 41 cents a share - Earnings Preview

Coya Therapeutics director Mark H. Pavao files initial beneficial ownership statement

Coya study links ALS inflammation biomarkers to survival, supporting COYA 302 rationale

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/COYA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","market":"US","secType":"STK","nameCN":"COYA THERAPEUTICS INC","latestPrice":4.55,"timestamp":1788465600000,"preClose":4.42,"halted":0,"volume":100314,"hourTrading":{"tag":"盘后","latestPrice":4.55,"preClose":4.55,"latestTime":"16:14 EDT","volume":2699,"amount":12315.449999999999,"timestamp":1788466463656,"change":0,"changeRate":0,"amplitude":0.004396},"delay":0,"changeRate":0.029411764705882328,"floatShares":17543500,"shares":23447199,"eps":-1.089684,"marketStatus":"Post-Mkt","change":0.13,"latestTime":"09-03 18:27:55 EDT","open":4.5,"high":4.58,"low":4.36,"amount":450061,"amplitude":0.049774,"askPrice":4.8,"askSize":500,"askPartCode":"p","bidPrice":4.54,"bidSize":100,"bidPartCode":"t","shortable":3,"etf":0,"ttmEps":-1.089684,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788480000000},"marketStatusCode":4,"adr":0,"listingDate":1672290000000,"exchange":"NASDAQ","adjPreClose":4.42,"preHourTrading":{"tag":"盘前","latestPrice":4.4901,"preClose":4.42,"latestTime":"09:29 EDT","volume":1031,"amount":4630.570000000001,"timestamp":1788442197059,"change":0.0701,"changeRate":0.01586,"amplitude":0.01586},"postHourTrading":{"tag":"盘后","latestPrice":4.55,"preClose":4.55,"latestTime":"16:14 EDT","volume":2699,"amount":12315.449999999999,"timestamp":1788466463656,"change":0,"changeRate":0,"amplitude":0.004396},"volumeRatio":1.136548,"impliedVol":0.298,"impliedVolPercentile":0.0873},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","floatShares":17543500,"roa":"-32.27%","roe":"-60.54%","lyrEps":-1.27,"volumeRatio":1.136548,"shares":23447199,"dividePrice":0,"high":4.58,"amplitude":0.049774,"preClose":4.42,"low":4.36,"week52Low":3.7101,"pbRate":"2.47","psRate":"13.30","week52High":7.75,"institutionHeld":0,"latestPrice":4.55,"committee":0.904762,"eps":-1.089684,"divideRate":0,"volume":100314,"delay":0,"ttmEps":-1.089684,"open":4.5,"prevYearClose":5.8,"prevWeekClose":4.59,"prevMonthClose":4.56,"prevQuarterClose":5.85,"fiveDayClose":4.86,"twentyDayClose":4.58,"sixtyDayClose":4.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"COYA","fiscalQuarterEnding":"2026/06","expectedEps":-0.36,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.28},{"market":"US","date":"2026-05-12","symbol":"COYA","fiscalQuarterEnding":"2026/03","expectedEps":-0.39,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2026-03-16","symbol":"COYA","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2025-11-12","symbol":"COYA","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-08-12","symbol":"COYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1787544000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COYA","date":"2026-09-02","current":-4.175522,"percent":0.687842,"low":-18.170827,"twenty":-9.478813,"median":-5.770144,"eighty":-4.116613,"high":-2.532969,"avg":-6.799698,"sd":3.246932,"marketCap":105791895},"quantilePoints":[{"date":"2022-12-30","current":-4.259584,"twenty":-5.088378,"median":-4.673981,"eighty":-4.199135,"marketCap":45862003},{"date":"2023-01-06","current":-4.198451,"twenty":-4.75686,"median":-4.211892,"eighty":-4.164199,"marketCap":45203803},{"date":"2023-01-13","current":-4.315322,"twenty":-4.421315,"median":-4.259584,"eighty":-4.180381,"marketCap":46462126},{"date":"2023-01-20","current":-4.288262,"twenty":-4.396143,"median":-4.253021,"eighty":-4.180381,"marketCap":46170776},{"date":"2023-01-27","current":-4.181765,"twenty":-4.394298,"median":-4.256303,"eighty":-4.180658,"marketCap":45024142},{"date":"2023-02-03","current":-3.675163,"twenty":-4.351211,"median":-4.234322,"eighty":-4.117451,"marketCap":39569675},{"date":"2023-02-10","current":-3.877804,"twenty":-4.30991,"median":-4.190108,"eighty":-3.84096,"marketCap":41751462},{"date":"2023-02-17","current":-3.850171,"twenty":-4.288262,"median":-4.180381,"eighty":-3.855698,"marketCap":41453946},{"date":"2023-02-24","current":-3.684374,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":39668848},{"date":"2023-03-03","current":-4.089655,"twenty":-4.270282,"median":-4.071233,"eighty":-3.770128,"marketCap":44032421},{"date":"2023-03-10","current":-4.23703,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":45619175},{"date":"2023-03-17","current":-3.905437,"twenty":-4.29377,"median":-4.180381,"eighty":-3.822538,"marketCap":42048978},{"date":"2023-03-24","current":-3.73964,"twenty":-4.288262,"median":-4.108461,"eighty":-3.73964,"marketCap":40263880},{"date":"2023-03-31","current":-3.218192,"twenty":-4.288262,"median":-4.048207,"eighty":-3.707402,"marketCap":39406041},{"date":"2023-04-06","current":-3.099387,"twenty":-4.273878,"median":-3.979124,"eighty":-3.684448,"marketCap":37951295},{"date":"2023-04-14","current":-3.233436,"twenty":-4.261724,"median":-3.905437,"eighty":-3.63832,"marketCap":39592701},{"date":"2023-04-21","current":-3.534032,"twenty":-4.256278,"median":-3.877804,"eighty":-3.512909,"marketCap":43273430},{"date":"2023-04-28","current":-3.753386,"twenty":-4.253993,"median":-3.850523,"eighty":-3.541339,"marketCap":45959367},{"date":"2023-05-05","current":-4.053981,"twenty":-4.248953,"median":-3.850876,"eighty":-3.590423,"marketCap":49640095},{"date":"2023-05-12","current":-3.858435,"twenty":-4.25448,"median":-3.877804,"eighty":-3.627267,"marketCap":51231762},{"date":"2023-05-19","current":-4.210564,"twenty":-4.257931,"median":-3.905437,"eighty":-3.63832,"marketCap":55907282},{"date":"2023-05-26","current":-3.109224,"twenty":-4.25448,"median":-3.877804,"eighty":-3.560217,"marketCap":41283847},{"date":"2023-06-02","current":-3.431385,"twenty":-4.251665,"median":-3.850876,"eighty":-3.429011,"marketCap":45561450},{"date":"2023-06-09","current":-3.611196,"twenty":-4.244399,"median":-3.84096,"eighty":-3.421013,"marketCap":47948950},{"date":"2023-06-16","current":-3.618688,"twenty":-4.23703,"median":-3.850171,"eighty":-3.424798,"marketCap":48048429},{"date":"2023-06-23","current":-3.566243,"twenty":-4.23703,"median":-3.830566,"eighty":-3.428417,"marketCap":47352075},{"date":"2023-06-30","current":-3.146685,"twenty":-4.23703,"median":-3.818461,"eighty":-3.418016,"marketCap":41781243},{"date":"2023-07-07","current":-3.071764,"twenty":-4.235405,"median":-3.785695,"eighty":-3.362458,"marketCap":40786451},{"date":"2023-07-14","current":-3.041795,"twenty":-4.228928,"median":-3.76675,"eighty":-3.288681,"marketCap":40388534},{"date":"2023-07-21","current":-2.981859,"twenty":-4.224887,"median":-3.746054,"eighty":-3.233436,"marketCap":39592701},{"date":"2023-07-28","current":-3.019319,"twenty":-4.216174,"median":-3.721218,"eighty":-3.218192,"marketCap":40090097},{"date":"2023-08-04","current":-2.876969,"twenty":-4.203296,"median":-3.712007,"eighty":-3.16841,"marketCap":38199993},{"date":"2023-08-11","current":-2.839996,"twenty":-4.188439,"median":-3.693585,"eighty":-3.145639,"marketCap":36807285},{"date":"2023-08-18","current":-2.54832,"twenty":-4.180935,"median":-3.684466,"eighty":-3.105289,"marketCap":33027077},{"date":"2023-08-25","current":-2.709509,"twenty":-4.180381,"median":-3.675163,"eighty":-3.078507,"marketCap":35116139},{"date":"2023-09-01","current":-2.709509,"twenty":-4.180381,"median":-3.63832,"eighty":-3.046291,"marketCap":35116139},{"date":"2023-09-08","current":-3.691995,"twenty":-4.169593,"median":-3.63832,"eighty":-3.044792,"marketCap":47849471},{"date":"2023-09-15","current":-3.546157,"twenty":-4.135431,"median":-3.63832,"eighty":-3.058278,"marketCap":45959367},{"date":"2023-09-21","current":-3.031887,"twenty":-4.1047,"median":-3.619293,"eighty":-3.053783,"marketCap":39294264},{"date":"2023-09-29","current":-3.162374,"twenty":-4.08252,"median":-3.599887,"eighty":-3.071764,"marketCap":40985409},{"date":"2023-10-06","current":-2.594374,"twenty":-4.053747,"median":-3.556227,"eighty":-3.033869,"marketCap":33623952},{"date":"2023-10-13","current":-3.745724,"twenty":-4.05097,"median":-3.54621,"eighty":-3.041795,"marketCap":48545825},{"date":"2023-10-20","current":-3.937616,"twenty":-4.036232,"median":-3.575206,"eighty":-3.043294,"marketCap":51032803},{"date":"2023-10-27","current":-3.645941,"twenty":-4.021495,"median":-3.590557,"eighty":-3.046291,"marketCap":47252596},{"date":"2023-11-03","current":-3.684319,"twenty":-3.985193,"median":-3.599887,"eighty":-3.062774,"marketCap":47749992},{"date":"2023-11-10","current":-3.870934,"twenty":-4.021495,"median":-3.619293,"eighty":-3.071764,"marketCap":47850465},{"date":"2023-11-17","current":-4.057134,"twenty":-4.055242,"median":-3.63832,"eighty":-3.071764,"marketCap":50152180},{"date":"2023-11-24","current":-4.259991,"twenty":-4.064747,"median":-3.645941,"eighty":-3.07577,"marketCap":52659789},{"date":"2023-12-01","current":-4.324905,"twenty":-4.105159,"median":-3.675163,"eighty":-3.082268,"marketCap":53462223},{"date":"2023-12-08","current":-5.631302,"twenty":-4.180381,"median":-3.684374,"eighty":-3.084048,"marketCap":69611225},{"date":"2023-12-15","current":-7.875233,"twenty":-4.205719,"median":-3.689056,"eighty":-3.088687,"marketCap":97349529},{"date":"2023-12-22","current":-7.933482,"twenty":-4.235947,"median":-3.693585,"eighty":-3.093672,"marketCap":98069570},{"date":"2023-12-29","current":-8.842163,"twenty":-4.23703,"median":-3.709704,"eighty":-3.09424,"marketCap":109302208},{"date":"2024-01-05","current":-7.793685,"twenty":-4.253993,"median":-3.715021,"eighty":-3.09424,"marketCap":96341472},{"date":"2024-01-12","current":-7.877698,"twenty":-4.259991,"median":-3.721218,"eighty":-3.097328,"marketCap":97379997},{"date":"2024-01-19","current":-6.724011,"twenty":-4.272114,"median":-3.742682,"eighty":-3.100019,"marketCap":83118725},{"date":"2024-01-26","current":-6.99204,"twenty":-4.300291,"median":-3.753386,"eighty":-3.10427,"marketCap":86431950},{"date":"2024-02-02","current":-7.213454,"twenty":-4.321125,"median":-3.76675,"eighty":-3.109224,"marketCap":89168961},{"date":"2024-02-09","current":-7.935965,"twenty":-4.359055,"median":-3.785695,"eighty":-3.121212,"marketCap":98100263},{"date":"2024-02-16","current":-8.91485,"twenty":-4.404211,"median":-3.812795,"eighty":-3.139255,"marketCap":110200736},{"date":"2024-02-23","current":-10.04523,"twenty":-4.438913,"median":-3.822509,"eighty":-3.140292,"marketCap":124173901},{"date":"2024-03-01","current":-10.476406,"twenty":-5.628056,"median":-3.830566,"eighty":-3.144593,"marketCap":129503871},{"date":"2024-03-08","current":-10.441446,"twenty":-5.900696,"median":-3.837832,"eighty":-3.146685,"marketCap":129071712},{"date":"2024-03-15","current":-11.653399,"twenty":-6.72168,"median":-3.850171,"eighty":-3.146685,"marketCap":144053250},{"date":"2024-03-22","current":-18.042053,"twenty":-6.870845,"median":-3.854655,"eighty":-3.146752,"marketCap":144116957},{"date":"2024-03-28","current":-17.568699,"twenty":-6.99204,"median":-3.858435,"eighty":-3.147022,"marketCap":140335887},{"date":"2024-04-05","current":-16.744948,"twenty":-7.213454,"median":-3.877804,"eighty":-3.154698,"marketCap":133755895},{"date":"2024-04-12","current":-16.708387,"twenty":-7.481482,"median":-3.895399,"eighty":-3.162374,"marketCap":133463852},{"date":"2024-04-19","current":-15.428751,"twenty":-7.933482,"median":-3.905437,"eighty":-3.168361,"marketCap":123242331},{"date":"2024-04-26","current":-15.41047,"twenty":-7.947618,"median":-3.91531,"eighty":-3.168442,"marketCap":123096309},{"date":"2024-05-03","current":-16.050288,"twenty":-8.108228,"median":-3.925864,"eighty":-3.184145,"marketCap":128207070},{"date":"2024-05-10","current":-15.465312,"twenty":-8.157379,"median":-3.945867,"eighty":-3.193076,"marketCap":123534375},{"date":"2024-05-17","current":-12.046492,"twenty":-8.434421,"median":-4.006757,"eighty":-3.19913,"marketCap":124118462},{"date":"2024-05-24","current":-12.027546,"twenty":-8.842163,"median":-4.037702,"eighty":-3.208428,"marketCap":123923260},{"date":"2024-05-31","current":-11.25722,"twenty":-9.523158,"median":-4.053396,"eighty":-3.216239,"marketCap":115986366},{"date":"2024-06-07","current":-10.62197,"twenty":-10.30363,"median":-4.063993,"eighty":-3.218192,"marketCap":109441204},{"date":"2024-06-14","current":-10.636743,"twenty":-10.491151,"median":-4.092919,"eighty":-3.222662,"marketCap":109593417},{"date":"2024-06-21","current":-8.937819,"twenty":-10.481448,"median":-4.104334,"eighty":-3.228445,"marketCap":92088913},{"date":"2024-06-28","current":-8.952592,"twenty":-10.45543,"median":-4.153411,"eighty":-3.232684,"marketCap":92241126},{"date":"2024-07-05","current":-9.602615,"twenty":-10.38956,"median":-4.180381,"eighty":-3.233436,"marketCap":98938502},{"date":"2024-07-12","current":-11.065167,"twenty":-10.462422,"median":-4.190108,"eighty":-3.233436,"marketCap":114007596},{"date":"2024-07-19","current":-10.341278,"twenty":-10.495432,"median":-4.22459,"eighty":-3.240692,"marketCap":106549156},{"date":"2024-07-26","current":-10.858342,"twenty":-10.601287,"median":-4.235676,"eighty":-3.260565,"marketCap":111876613},{"date":"2024-08-02","current":-9.30715,"twenty":-10.601287,"median":-4.23703,"eighty":-3.276491,"marketCap":95894240},{"date":"2024-08-09","current":-8.952592,"twenty":-10.592423,"median":-4.254237,"eighty":-3.285234,"marketCap":92241126},{"date":"2024-08-16","current":-7.71646,"twenty":-10.555339,"median":-4.259991,"eighty":-3.293463,"marketCap":77933096},{"date":"2024-08-23","current":-9.253723,"twenty":-10.495432,"median":-4.262601,"eighty":-3.309966,"marketCap":93458831},{"date":"2024-08-30","current":-9.08794,"twenty":-10.483969,"median":-4.273335,"eighty":-3.333614,"marketCap":91784487},{"date":"2024-09-06","current":-9.057798,"twenty":-10.475972,"median":-4.288262,"eighty":-3.336985,"marketCap":91480061},{"date":"2024-09-13","current":-9.645575,"twenty":-10.467679,"median":-4.305376,"eighty":-3.353467,"marketCap":97416371},{"date":"2024-09-20","current":-9.20851,"twenty":-10.421412,"median":-4.315454,"eighty":-3.374246,"marketCap":93002191},{"date":"2024-09-27","current":-10.188138,"twenty":-10.338323,"median":-4.344348,"eighty":-3.38688,"marketCap":102896042},{"date":"2024-10-04","current":-10.941699,"twenty":-10.338323,"median":-4.360183,"eighty":-3.395897,"marketCap":110506696},{"date":"2024-10-11","current":-10.625204,"twenty":-10.475972,"median":-4.389011,"eighty":-3.411186,"marketCap":107310221},{"date":"2024-10-18","current":-12.056969,"twenty":-10.583908,"median":-4.422276,"eighty":-3.421013,"marketCap":121770464},{"date":"2024-10-25","current":-13.503805,"twenty":-10.624557,"median":-4.764496,"eighty":-3.424798,"marketCap":136382919},{"date":"2024-11-01","current":-10.610132,"twenty":-10.639569,"median":-5.615074,"eighty":-3.429011,"marketCap":107158008},{"date":"2024-11-08","current":-11.259019,"twenty":-10.689241,"median":-5.753016,"eighty":-3.447868,"marketCap":120460649},{"date":"2024-11-15","current":-9.869209,"twenty":-10.838842,"median":-5.907187,"eighty":-3.515296,"marketCap":105591027},{"date":"2024-11-22","current":-10.150294,"twenty":-10.747842,"median":-6.613304,"eighty":-3.52129,"marketCap":108598366},{"date":"2024-11-29","current":-10.181526,"twenty":-10.695836,"median":-6.758971,"eighty":-3.52129,"marketCap":108932515},{"date":"2024-12-06","current":-9.556893,"twenty":-10.66286,"median":-6.852199,"eighty":-3.534032,"marketCap":102249538},{"date":"2024-12-13","current":-9.197728,"twenty":-10.640275,"median":-6.968732,"eighty":-3.546157,"marketCap":98406827},{"date":"2024-12-20","current":-8.182699,"twenty":-10.636743,"median":-6.99204,"eighty":-3.54621,"marketCap":87546990},{"date":"2024-12-27","current":-9.244576,"twenty":-10.634857,"median":-7.16684,"eighty":-3.558448,"marketCap":98908050},{"date":"2025-01-03","current":-9.541277,"twenty":-10.628876,"median":-7.256788,"eighty":-3.564349,"marketCap":102082464},{"date":"2025-01-10","current":-9.010338,"twenty":-10.62391,"median":-7.341641,"eighty":-3.567419,"marketCap":96401934},{"date":"2025-01-17","current":-8.401321,"twenty":-10.617235,"median":-7.51608,"eighty":-3.569184,"marketCap":89886032},{"date":"2025-01-24","current":-9.213344,"twenty":-10.609545,"median":-7.731531,"eighty":-3.571593,"marketCap":98573901},{"date":"2025-01-31","current":-9.494429,"twenty":-10.604242,"median":-7.875233,"eighty":-3.584959,"marketCap":101581241},{"date":"2025-02-07","current":-10.665617,"twenty":-10.609545,"median":-7.934724,"eighty":-3.602149,"marketCap":114111822},{"date":"2025-02-14","current":-10.61877,"twenty":-10.62133,"median":-7.947618,"eighty":-3.612694,"marketCap":113610598},{"date":"2025-02-21","current":-10.009752,"twenty":-10.61877,"median":-7.957599,"eighty":-3.618688,"marketCap":107094696},{"date":"2025-02-28","current":-11.056013,"twenty":-10.61877,"median":-8.042226,"eighty":-3.619898,"marketCap":118288682},{"date":"2025-03-07","current":-10.743696,"twenty":-10.62197,"median":-8.108228,"eighty":-3.622913,"marketCap":114947194},{"date":"2025-03-14","current":-10.134679,"twenty":-10.61877,"median":-8.140788,"eighty":-3.63832,"marketCap":108431292},{"date":"2025-03-21","current":-7.507868,"twenty":-10.61877,"median":-8.131528,"eighty":-3.63832,"marketCap":111722986},{"date":"2025-03-28","current":-7.372996,"twenty":-10.610132,"median":-8.0597,"eighty":-3.645941,"marketCap":109715986},{"date":"2025-04-04","current":-6.125431,"twenty":-10.607197,"median":-8.00338,"eighty":-3.648656,"marketCap":91151239},{"date":"2025-04-11","current":-5.81073,"twenty":-10.603154,"median":-7.947618,"eighty":-3.675163,"marketCap":86468239},{"date":"2025-04-17","current":-5.911884,"twenty":-10.594569,"median":-7.935965,"eighty":-3.675163,"marketCap":87973489},{"date":"2025-04-25","current":-6.945902,"twenty":-10.592423,"median":-7.877698,"eighty":-3.682488,"marketCap":103360487},{"date":"2025-05-02","current":-7.159449,"twenty":-10.558363,"median":-7.770143,"eighty":-3.684363,"marketCap":106538237},{"date":"2025-05-09","current":-6.799791,"twenty":-10.517537,"median":-7.71646,"eighty":-3.684448,"marketCap":101186237},{"date":"2025-05-16","current":-5.787895,"twenty":-10.501662,"median":-7.494675,"eighty":-3.685787,"marketCap":99179238},{"date":"2025-05-23","current":-5.573167,"twenty":-10.491151,"median":-7.462911,"eighty":-3.690819,"marketCap":95499738},{"date":"2025-05-30","current":-5.204226,"twenty":-10.481448,"median":-7.372996,"eighty":-3.692949,"marketCap":89177689},{"date":"2025-06-06","current":-5.631729,"twenty":-10.475105,"median":-7.356137,"eighty":-3.693585,"marketCap":96503238},{"date":"2025-06-13","current":-5.241315,"twenty":-10.467261,"median":-7.341641,"eighty":-3.701875,"marketCap":89813239},{"date":"2025-06-20","current":-5.37796,"twenty":-10.461335,"median":-7.3168,"eighty":-3.709244,"marketCap":92154738},{"date":"2025-06-27","current":-5.758614,"twenty":-10.45223,"median":-7.265955,"eighty":-3.713213,"marketCap":98677488},{"date":"2025-07-03","current":-5.817176,"twenty":-10.430063,"median":-7.253076,"eighty":-3.716195,"marketCap":99680988},{"date":"2025-07-11","current":-6.17343,"twenty":-10.378286,"median":-7.213454,"eighty":-3.720955,"marketCap":105785612},{"date":"2025-07-18","current":-5.817176,"twenty":-10.3533,"median":-7.163144,"eighty":-3.721218,"marketCap":99680988},{"date":"2025-07-25","current":-6.558964,"twenty":-10.350896,"median":-7.092013,"eighty":-3.724902,"marketCap":112391986},{"date":"2025-08-01","current":-5.807416,"twenty":-10.338323,"median":-6.99204,"eighty":-3.740857,"marketCap":99513738},{"date":"2025-08-08","current":-5.953821,"twenty":-10.32596,"median":-6.97962,"eighty":-3.74579,"marketCap":102022487},{"date":"2025-08-15","current":-4.674882,"twenty":-10.323437,"median":-6.940283,"eighty":-3.74752,"marketCap":95082085},{"date":"2025-08-22","current":-5.41908,"twenty":-10.320001,"median":-6.875506,"eighty":-3.754924,"marketCap":110218283},{"date":"2025-08-29","current":-5.517759,"twenty":-10.309706,"median":-6.854093,"eighty":-3.761854,"marketCap":112225293},{"date":"2025-09-05","current":-5.246393,"twenty":-10.301605,"median":-6.808515,"eighty":-3.76497,"marketCap":106706016},{"date":"2025-09-12","current":-5.106599,"twenty":-10.301173,"median":-6.724011,"eighty":-3.76853,"marketCap":103862753},{"date":"2025-09-19","current":-4.720109,"twenty":-10.296958,"median":-6.63442,"eighty":-3.770128,"marketCap":96001964},{"date":"2025-09-26","current":-4.366512,"twenty":-10.282185,"median":-6.51425,"eighty":-3.785695,"marketCap":88810180},{"date":"2025-10-03","current":-4.827011,"twenty":-10.275221,"median":-6.439507,"eighty":-3.802131,"marketCap":98176225},{"date":"2025-10-10","current":-5.155938,"twenty":-10.212758,"median":-6.246632,"eighty":-3.807129,"marketCap":104866257},{"date":"2025-10-17","current":-5.180608,"twenty":-10.197142,"median":-6.190468,"eighty":-3.818461,"marketCap":105368010},{"date":"2025-10-24","current":-5.739785,"twenty":-10.188138,"median":-6.125431,"eighty":-3.822481,"marketCap":116741065},{"date":"2025-10-31","current":-5.03259,"twenty":-10.181526,"median":-6.064471,"eighty":-3.822538,"marketCap":102357495},{"date":"2025-11-07","current":-4.736556,"twenty":-10.181526,"median":-6.012384,"eighty":-3.830156,"marketCap":96336466},{"date":"2025-11-14","current":-4.901019,"twenty":-10.157996,"median":-5.968462,"eighty":-3.830566,"marketCap":99681482},{"date":"2025-11-21","current":-6.788148,"twenty":-10.150294,"median":-6.012384,"eighty":-3.831749,"marketCap":125128246},{"date":"2025-11-28","current":-7.389773,"twenty":-10.150294,"median":-6.057995,"eighty":-3.836615,"marketCap":136218208},{"date":"2025-12-05","current":-6.810851,"twenty":-10.140824,"median":-6.125431,"eighty":-3.837832,"marketCap":125546736},{"date":"2025-12-12","current":-7.094636,"twenty":-10.135435,"median":-6.18807,"eighty":-3.843973,"marketCap":130777850},{"date":"2025-12-19","current":-6.016252,"twenty":-10.134497,"median":-6.219749,"eighty":-3.849238,"marketCap":110899616},{"date":"2025-12-26","current":-6.300037,"twenty":-10.125219,"median":-6.23928,"eighty":-3.850171,"marketCap":116130730},{"date":"2026-01-02","current":-6.583822,"twenty":-10.098465,"median":-6.246632,"eighty":-3.850453,"marketCap":121361844},{"date":"2026-01-09","current":-5.811926,"twenty":-10.058633,"median":-6.231928,"eighty":-3.8539,"marketCap":107133214},{"date":"2026-01-16","current":-4.574621,"twenty":-10.039554,"median":-6.190468,"eighty":-3.858435,"marketCap":84325557},{"date":"2026-01-23","current":-5.369221,"twenty":-10.03081,"median":-6.14943,"eighty":-3.858435,"marketCap":98972676},{"date":"2026-01-30","current":-5.221652,"twenty":-10.025863,"median":-6.08436,"eighty":-3.860935,"marketCap":96252497},{"date":"2026-02-06","current":-5.622234,"twenty":-10.005146,"median":-6.077653,"eighty":-3.872308,"marketCap":103636548},{"date":"2026-02-13","current":-6.029273,"twenty":-9.98508,"median":-6.08436,"eighty":-3.877804,"marketCap":111139647},{"date":"2026-02-20","current":-6.169193,"twenty":-9.97852,"median":-6.08436,"eighty":-3.877804,"marketCap":113718837},{"date":"2026-02-27","current":-6.334553,"twenty":-9.962904,"median":-6.104895,"eighty":-3.891562,"marketCap":116766971},{"date":"2026-03-06","current":-6.029273,"twenty":-9.957173,"median":-6.125431,"eighty":-3.899237,"marketCap":111139647},{"date":"2026-03-13","current":-6.041993,"twenty":-9.931673,"median":-6.125431,"eighty":-3.905437,"marketCap":111374119},{"date":"2026-03-20","current":-4.71882,"twenty":-9.928914,"median":-6.08436,"eighty":-3.905437,"marketCap":100162171},{"date":"2026-03-27","current":-4.61936,"twenty":-9.927627,"median":-6.064471,"eighty":-3.91088,"marketCap":98051024},{"date":"2026-04-02","current":-4.508849,"twenty":-9.918371,"median":-6.053489,"eighty":-3.913847,"marketCap":95705306},{"date":"2026-04-10","current":-5.006148,"twenty":-9.878579,"median":-6.029273,"eighty":-3.915743,"marketCap":106261038},{"date":"2026-04-17","current":-4.950893,"twenty":-9.831731,"median":-6.014318,"eighty":-3.918609,"marketCap":105088179},{"date":"2026-04-24","current":-4.796177,"twenty":-9.776569,"median":-5.991113,"eighty":-3.924542,"marketCap":101804174},{"date":"2026-05-01","current":-4.674615,"twenty":-9.735958,"median":-5.962584,"eighty":-3.935266,"marketCap":99223884},{"date":"2026-05-08","current":-4.641462,"twenty":-9.722478,"median":-5.952953,"eighty":-3.939718,"marketCap":98520168},{"date":"2026-05-15","current":-5.840329,"twenty":-9.714627,"median":-5.92942,"eighty":-3.949241,"marketCap":123384782},{"date":"2026-05-22","current":-5.373991,"twenty":-9.700558,"median":-5.914793,"eighty":-3.966952,"marketCap":113532765},{"date":"2026-05-29","current":-5.362888,"twenty":-9.666319,"median":-5.907187,"eighty":-3.992381,"marketCap":113298193},{"date":"2026-06-05","current":-5.407301,"twenty":-9.639213,"median":-5.897213,"eighty":-4.017509,"marketCap":114236481},{"date":"2026-06-12","current":-5.151925,"twenty":-9.634972,"median":-5.866927,"eighty":-4.028953,"marketCap":108841329},{"date":"2026-06-18","current":-5.584954,"twenty":-9.622479,"median":-5.858502,"eighty":-4.036522,"marketCap":117989630},{"date":"2026-06-26","current":-5.695987,"twenty":-9.60329,"median":-5.861207,"eighty":-4.047285,"marketCap":120335348},{"date":"2026-07-02","current":-6.284461,"twenty":-9.598183,"median":-5.870283,"eighty":-4.053046,"marketCap":132767655},{"date":"2026-07-10","current":-5.840329,"twenty":-9.575743,"median":-5.87473,"eighty":-4.054612,"marketCap":123384782},{"date":"2026-07-17","current":-5.107512,"twenty":-9.556893,"median":-5.86542,"eighty":-4.058506,"marketCap":107903041},{"date":"2026-07-24","current":-4.86324,"twenty":-9.55377,"median":-5.856218,"eighty":-4.064244,"marketCap":102742461},{"date":"2026-07-31","current":-4.530141,"twenty":-9.541277,"median":-5.840329,"eighty":-4.065249,"marketCap":95705306},{"date":"2026-08-07","current":-5.085306,"twenty":-9.510045,"median":-5.833633,"eighty":-4.089655,"marketCap":107433898},{"date":"2026-08-14","current":-5.055235,"twenty":-9.494429,"median":-5.817176,"eighty":-4.096184,"marketCap":109545044},{"date":"2026-08-21","current":-5.260909,"twenty":-9.494429,"median":-5.811328,"eighty":-4.100207,"marketCap":114001909},{"date":"2026-08-28","current":-5.260909,"twenty":-9.478813,"median":-5.787895,"eighty":-4.108461,"marketCap":114001909},{"date":"2026-09-02","current":-4.882037,"twenty":-9.478813,"median":-5.770144,"eighty":-4.116613,"marketCap":105791895}],"updateTime":1788474474329},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COYA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641878112","title":"Coya Therapeutics Initiated at Buy by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2641878112","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641878112?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:39","pubTimestamp":1780655940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COYA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2026 06:39 ET (10:39 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA","BK4539","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641115542","title":"Coya Therapeutics initiated with a Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2641115542","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641115542?lang=en_us&edition=fundamental","pubTime":"2026-06-05 16:20","pubTimestamp":1780647606,"startTime":"0","endTime":"0","summary":"Roth Capital initiated coverage of Coya Therapeutics (COYA) with a Buy rating and $12 price target The firm says its bullish view is predicated on ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","COYA","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640595901","title":"Coya Therapeutics releases investor presentation on Treg-directed combination therapies for neurodegenerative diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2640595901","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640595901?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:07","pubTimestamp":1780315635,"startTime":"0","endTime":"0","summary":"Coya outlined a Treg-directed combination-therapy strategy for neurodegenerative diseases, led by COYA 302 in ALS and frontotemporal dementia.ALSTARS Phase 2 ALS study remains active; enrollment completion targeted for 2H 2026; top-line data expected in 1Q 2027.FTD program advanced with IND accepted in 1Q 2026; Phase 2a initiation expected in 2H 2026.Cash runway estimated into 2H 2027; cash balance of about $50.7 million as of March 31, 2026.Dr. Reddy’s partnership includes royalties, up to about $700 million in milestones, and a $10 million strategic investment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief on May 29, 2026, and is solely responsibl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL9hHXxj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507257","title":"Coya Therapeutics presents ALSTARS Phase 2 trial design at ALS Drug Development Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507257?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:03","pubTimestamp":1779883433,"startTime":"0","endTime":"0","summary":"Coya Therapeutics will present the ALSTARS Phase 2 trial design for COYA 302 at the 5th ALS Drug Development Summit in Boston, June 2-4, 2026.A poster session is scheduled for June 3, 2026 at 4:45 p.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL14khCM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637310178","title":"Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637310178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637310178?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:20","pubTimestamp":1779459618,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-coya-therapeutics-inc-coya-beta-bionics-inc-bbnx-and-arvinas-holding-company-arvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-coya-therapeutics-inc-coya-beta-bionics-inc-bbnx-and-arvinas-holding-company-arvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4588","HCSG","COYA","LU0029874061.USD","BK4581","XBI","LABU","XLV","BK4137","BK4139","BK4082","BK4585","BBNX","ARVN","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635735553","title":"Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2635735553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635735553?lang=en_us&edition=fundamental","pubTime":"2026-05-13 22:37","pubTimestamp":1778683028,"startTime":"0","endTime":"0","summary":"Lake Street analyst Chad Messer maintained a Buy rating on Coya Therapeutics, Inc. today and set a price target of $17.00. Messer covers the Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/coya-therapeutics-inc-coya-gets-a-buy-from-lake-street-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/coya-therapeutics-inc-coya-gets-a-buy-from-lake-street-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635826417","title":"Coya Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2635826417","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635826417?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:31","pubTimestamp":1778675500,"startTime":"0","endTime":"0","summary":"Virtual annual stockholders meeting set for June 25, 2026.Shareholders to vote on election of two Class I directors, including Wilbur Ross and Dieter Weinand, for terms running to 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL1KwB2Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634243690","title":"Coya Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634243690","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634243690?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:13","pubTimestamp":1778598802,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryCoya Therapeutics Inc COYA.OQ reported a quarterly adjusted loss of 32 cents per share for the quarter ended Marc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P2EY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634211778","title":"Coya Therapeutics: Entered Into Sales Agreement, May Offer and Sell From Time to Time Shares of Co's Common Stock for up to $30 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2634211778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634211778?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:50","pubTimestamp":1778590207,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P0TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634621121","title":"Coya Therapeutics enters at-the-market equity sales agreement for up to $30 million stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2634621121","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634621121?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:49","pubTimestamp":1778590150,"startTime":"0","endTime":"0","summary":"Coya Therapeutics entered sales agreement with Leerink Partners for an at-the-market equity program of up to USD 30 million of common stock.Shares may be sold from time to time through Leerink Partners, including sales on Nasdaq.Leerink Partners will receive 3% commission on gross proceeds from any shares sold.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL2zLnD2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNSH","BK4139","COYA","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634475216","title":"Coya Therapeutics granted FDA Fast Track Designation for COYA 302","url":"https://stock-news.laohu8.com/highlight/detail?id=2634475216","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634475216?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:54","pubTimestamp":1778586870,"startTime":"0","endTime":"0","summary":"Coya Therapeutics (COYA) announced that the U.S. Food and Drug Administration has granted Fast Track Designation for COYA 302, a proprietary invest...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-granted-fda-fast-track-designation-for-coya-302-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-granted-fda-fast-track-designation-for-coya-302-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215489","title":"Coya Therapeutics Q1 FY26 net loss narrows to $7.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215489","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215489?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:35","pubTimestamp":1778585757,"startTime":"0","endTime":"0","summary":"Coya Therapeutics posted a net loss of $7.2 million, or $0.32 per share, for quarter ended March 31, 2026.Research and development expense fell to $4.1 million, while general and administrative expense climbed to $3.8 million.Cash and cash equivalents totaled $50.7 million as of March 31, 2026.FDA granted Fast Track designation to COYA 302 for ALS, while the IND for COYA 302 in frontotemporal dementia was accepted.Management said ALSTARS Phase 2 trial is in full recruitment mode, maintaining guidance for a 1Q 2027 topline readout.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 12, 2026, and is solely responsible for the info","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL6lghld:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634151032","title":"Coya Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2634151032","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634151032?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:35","pubTimestamp":1778585700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA7L1KJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634106215","title":"Coya Therapeutics Q1 Net Income USD -7.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634106215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634106215?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:35","pubTimestamp":1778585700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLX3D852C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215908","title":"Coya Therapeutics wins FDA fast track status for ALS drug COYA 302","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215908","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215908?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:34","pubTimestamp":1778585680,"startTime":"0","endTime":"0","summary":"Coya Therapeutics received U.S. FDA Fast Track designation for COYA 302 in amyotrophic lateral sclerosis.Fast Track status can speed development through closer FDA interaction, rolling review options, accelerated approval eligibility.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief on May 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL9BSD9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634321565","title":"Coya Therapeutics Inc - Conducting Phase 2 Alstars Trial of Coya 302 for ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2634321565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634321565?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUALKCZG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215578","title":"Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for Coya 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215578?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUALKCZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633685594","title":"Coya Therapeutics Inc  expected to post a loss of 41 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633685594","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633685594?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:31","pubTimestamp":1778254268,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc  expected to post a loss of41cents a share - Earnings Preview Coya Therapeutics Inc COYA.OQ COYA.O is expected to  show a fall in quarterly revenue when it reports  results on Ma","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L1VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626155705","title":"Coya Therapeutics director Mark H. Pavao files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626155705","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626155705?lang=en_us&edition=fundamental","pubTime":"2026-04-10 06:43","pubTimestamp":1775774594,"startTime":"0","endTime":"0","summary":"Coya Therapeutics director Mark H. Pavao filed an initial Form 3 beneficial ownership statement dated April 1.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDLbh58tP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626181045","title":"Coya study links ALS inflammation biomarkers to survival, supporting COYA 302 rationale","url":"https://stock-news.laohu8.com/highlight/detail?id=2626181045","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626181045?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:00","pubTimestamp":1775736053,"startTime":"0","endTime":"0","summary":"Coya Therapeutics disclosed publication of a longitudinal ALS biomarker study, with results already presented in a peer-reviewed journal.Study linked higher inflammation, oxidative stress, and nerve-injury signals to faster functional decline and shorter survival, supporting mechanistic rationale for COYA 302.Coya highlighted prior academic testing of COYA 302 components that showed reduced inflammatory signals and stable patient function over the treatment period.Ongoing ALSTARS trial is tracking neurofilament light chain as a secondary endpoint, with inflammation-related markers as exploratory endpoints.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news bri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL4SgYNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":49,"code":"91000000","status":"200"}]}}